Chronic myelogenous leukemia

Disease ID:1224
Name:Chronic myelogenous leukemia
Associated with:0 targets
0 immuno targets immuno relevant
1 immuno ligands
chronic granulocytic leukemia | CML | myeloid leukemia, chronic
A myeloid leukemia characterized by over production of white blood cells.
Database Links
Disease Ontology: DOID:8552
OMIM: 608232


No target related data available for Chronic myelogenous leukemia


Ligand Approved Immuno References Clinical comments
imatinib  [ FDA & EMA (2001) ( ]
Clinical Use: Used in the treatment of multiple cancers including chronic myelogenous leukemia and gastrointestinal stromal tumours (GIST). Adjuvant imatinib is recommended for KIT-mutated GISTs. The clinically administered form is the Imatinib mesilate (mesylate) salt (PubChem CID 123596).
Generic imatinib mesylate tablets were approved by the US FDA in December 2015, as therapeutic equivalents of Novartis' original Gleevec.
Immuno Disease Comments: Approved drug for CML.